Market Cap: $515.62M
DI
Delcath Systems, Inc.
DCTH
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $515.62M
Delcath Systems Achieves Significant Revenue Growth Amid Expanding Oncology Innovations Delcath Systems reports notable financial developments in its most recent Q4 earnings, showcasing a marked incre…
Delcath Systems Reports Strong Q4 Earnings with Growth in Oncology Treatments Delcath Systems, a key player in the oncology sector, announces its Q4 earnings for the period ending on February 26, 2026…
Delcath Systems: Pioneering Innovations in Cancer Treatment Delcath Systems stands at the forefront of cancer treatment innovation, particularly with its proprietary hepatic delivery system designed t…
Delcath Systems Expands Treatment Options for Metastatic Uveal Melanoma Delcath Systems, Inc. announces a significant milestone in its ongoing commitment to interventional oncology for liver cancers w…
Delcath Systems Advances Interventional Oncology with Innovative Liver Cancer Treatments Delcath Systems, Inc., a pioneering interventional oncology company based in Queensbury, NY, focuses on address…
Delcath Systems Advances Cancer Treatment with HEPZATO KIT™ Delcath Systems, Inc., a Queensbury-based interventional oncology company, is making significant strides in the treatment of primary and met…
Delcath Systems Reports Strong Revenue Projections for 2024: A Focus on Innovative Cancer Treatments Delcath Systems, Inc., a key player in the interventional oncology sector, announces promising prel…
Delcath Systems Enhances Workforce with New Equity Award Amid Innovative Oncology Solutions Delcath Systems, Inc., an interventional oncology company that specializes in the treatment of liver cancers…
Delcath Systems Secures Funding to Advance Liver Cancer Treatments Delcath Systems, Inc., an interventional oncology company focusing on innovative treatments for liver cancers, announces the exercise…
Clear Street Launches Healthcare Research to Support Biotechnology Investments Clear Street, a cloud-native financial technology firm, announces a strategic expansion of its equity research services,…
Clear Street Expands Equity Research to Focus on Biotechnology Clear Street, a cloud-native financial technology firm, announces a significant expansion of its equity research offerings aimed at the h…
Delcath Systems Strengthens Position in Interventional Oncology with Robust Q3 Results Delcath Systems, Inc., a company dedicated to advancing treatment options for liver cancer, announces substantial…
Delcath Systems to Showcase Innovative Liver Cancer Treatments at Upcoming Conferences Delcath Systems, Inc., an interventional oncology firm focused on innovative therapies for liver cancers, prepare…